AstraZeneca PLC is 253.6x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($286.27 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COLL | AZN |
|---|---|---|
| Market cap | $1.13 B | $286.27 B |
| US-listed rank | #2551 | #45 |
| Revenue (latest FY) | $780.57M | - |
| Net income (latest FY) | $63.00M | - |
| Net margin | 8.1% | - |
| P/E (trailing FY) | 17.9 | - |
| SEC filings | 849 | 1,004 |
AstraZeneca PLC is 253.6x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($286.27 B vs $1.13 B).
Full pages: COLLEGIUM PHARMACEUTICAL, INC and AstraZeneca PLC, or browse the full rankings.